Challenges of efficacy assessments in pseudomyxoma peritonea.
Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Michael J
MJ
Overman
Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cathy
C
Eng
Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kanwal
K
Raghav
Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Aurelio
A
Matamoros
Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Melissa
M
Taggart
Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wai Chin
WC
Foo
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Keith
K
Fournier
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D010534:Peritoneal Neoplasms / Q000188:drug therapy*; D011553:Pseudomyxoma Peritonei / Q000188:drug therapy*